Irlanda -
inglês -
HPRA (Health Products Regulatory Authority)
slow k 600 milligram tablet prolonged release
novartis pharmaceuticals uk ltd - potassium chloride - tablet prolonged release - 600 milligram
União Europeia -
inglês -
EMA (European Medicines Agency)
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
Austrália -
inglês -
Department of Health (Therapeutic Goods Administration)
amlodipine/valsartan novartis 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack
novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
neoral 50mg capsules
novartis pharmaceuticals uk ltd - ciclosporin - oral capsule - 50mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
neoral 100mg capsules
novartis pharmaceuticals uk ltd - ciclosporin - oral capsule - 100mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
simulect 20mg powder and solvent for solution for injection vials
novartis pharmaceuticals uk ltd - basiliximab - powder and solvent for solution for injection - 20mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
visudyne 15mg powder for solution for infusion vials
novartis pharmaceuticals uk ltd - verteporfin - powder for solution for infusion - 15mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
simulect 10mg powder and solvent for solution for injection vials
novartis pharmaceuticals uk ltd - basiliximab - powder and solvent for solution for injection - 10mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glivec 400mg tablets
novartis pharmaceuticals uk ltd - imatinib mesilate - tablet - 400mg
Reino Unido -
inglês -
MHRA (Medicines & Healthcare Products Regulatory Agency)
zometa 4mg5ml solution for infusion vials
novartis pharmaceuticals uk ltd - zoledronic acid monohydrate - solution for infusion - 800microgram/1ml